Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

PERIGON Pivotal Trial

NCT: NCT02088554 · ACTIVE_NOT_RECRUITING

NCT IDNCT02088554
StatusACTIVE_NOT_RECRUITING
Start Date2014-05-12
Completion2035-12-31

Brief Summary

To evaluate the safety and effectiveness of the Model 400 aortic valve bioprosthesis.

Frequently Asked Questions

What is PERIGON Pivotal Trial?

PERIGON Pivotal Trial is a clinical trial registered under NCT02088554. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT02088554?

The current status of NCT02088554 (PERIGON Pivotal Trial) is: ACTIVE_NOT_RECRUITING.

When did PERIGON Pivotal Trial start?

PERIGON Pivotal Trial started on 2014-05-12.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.